Gentagen indgift af infliximab (5 mg/ kg ved 0, 2 og 6 uger i fistulerende Crohns sygdom, 3 eller 10 mg/ kg hver 4. eller 8. uge i rheumatoid arthritis) resulterede i en let akkumulering af infliximab i serum efter den anden dosis.
Repeated administration of infliximab (5 mg/ kg at 0, 2 and 6 weeks in fistulising Crohn´s disease, 3 or 10 mg/ kg every 4 or 8 weeks in rheumatoid arthritis) resulted in a slight accumulation of infliximab in serum after the second dose.